Search Results - Baerin Houghton

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Pembrolizumab 400 mg every 6 weeks as first-line therapy for advanced melanoma (KEYNOTE-555): Results from cohort B of an open-label, phase 1 study

    Pembrolizumab 400 mg every 6 weeks as first-line therapy for advanced melanoma (KEYNOTE-555): Results from cohort B of an open-label, phase 1 study by Cohen, Graham, Rapoport, Bernardo, Chan, Sze W, Ruff, Paul, Arance, Ana, Mujika Eizmendi, Karmele, Houghton, Baerin, Brown, Michael P, Zielinski, Robert M, Muñoz Couselo, Eva, Lyle, Megan, Anderson, James R, Jain, Lokesh, de Alwis, Dinesh, Lala, Mallika, Akala, Omobolaji, Chartash, Elliot, Jacobs, Conrad

    Published in PloS one
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    Intravesical chemotherapy plus bacille Calmette‐Guérin in non‐muscle invasive bladder cancer: a systematic review with meta‐analysis

    Intravesical chemotherapy plus bacille Calmette‐Guérin in non‐muscle invasive bladder cancer: a systematic review with meta‐analysis by Houghton, Baerin B., Chalasani, Venu, Hayne, Dickon, Grimison, Peter, Brown, Christopher S. B., Patel, Manish I., Davis, Ian D., Stockler, Martin R.

    Published in BJU international
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non–small cell lung cancer without tumor PD‐L1 expression: A pooled analysis of 3 randomized controlled trials

    Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non–small cell lung cancer without tumor PD‐L1 expression: A pooled analysis of 3 randomized con... by Borghaei, Hossein, Langer, Corey J., Paz‐Ares, Luis, Rodríguez‐Abreu, Delvys, Halmos, Balazs, Garassino, Marina C., Houghton, Baerin, Kurata, Takayasu, Cheng, Ying, Lin, Jianxin, Pietanza, M. Catherine, Piperdi, Bilal, Gadgeel, Shirish M.

    Published in Cancer
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Pembrolizumab 400 mg every 6 weeks as first-line therapy for advanced melanoma

    Pembrolizumab 400 mg every 6 weeks as first-line therapy for advanced melanoma by Cohen, Graham, Rapoport, Bernardo, Chan, Sze W, Ruff, Paul, Arance, Ana, Mujika Eizmendi, Karmele, Houghton, Baerin, Brown, Michael P, Zielinski, Robert M, Muñoz Couselo, Eva, Lyle, Megan, Anderson, James R, Jain, Lokesh, de Alwis, Dinesh, Lala, Mallika, Akala, Omobolaji, Chartash, Elliot, Jacobs, Conrad

    Published in PloS one
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Abstract CT288: Phase 3, randomized, placebo-controlled study of stereotactic body radiotherapy (SBRT) with or without pembrolizumab in patients with inoperable stage I/IIA non-small-cell lung cancer (NSCLC): KEYNOTE-867

    Abstract CT288: Phase 3, randomized, placebo-controlled study of stereotactic body radiotherapy (SBRT) with or without pembrolizumab in patients with inoperable stage I/IIA non-sma... by Jabbour, Salma K., Houghton, Baerin, Robinson, Andrew G., Quantin, Xavier, Wehler, Thomas, Kowalski, Dariusz, Ahn, Myung-Ju, Erman, Mustafa, Giaccone, Giuseppe, Borghaei, Hossein, McLean, Jessica, Zhang, Jin, Souza, Fabricio, Decker, Roy

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Abstract A084: DENALI: a 3-arm double-blind randomized phase 2 study of carboplatin, pemetrexed, and placebo (CPP) versus carboplatin, pemetrexed, and either 1 or 2 truncated courses of demcizumab (CPD) in patients with non-squamous non-small cell lung cancer (NSCLC)

    Abstract A084: DENALI: a 3-arm double-blind randomized phase 2 study of carboplatin, pemetrexed, and placebo (CPP) versus carboplatin, pemetrexed, and either 1 or 2 truncated cours... by Hughes, Brett, Dean, Andrew, Markman, Ben, Dreisbach, Luke, Provencio, Mariano, Ciuffreda, Libero, Dear, Rachel, Graze, Peter, Nadal, Alforia, Houghton, Baerin, Moran, Teresa, Roberts, Rachel, Dy, Grace, Alvaro, Taus, Martinez Marti, Alex, Brachmann, Rainer, Stagg, Robert, Govindan, Ramaswamy

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Pembrolizumab 400 mg every 6 weeks as first-line therapy for advanced melanoma (KEYNOTE-555): Results from cohort B of an open-label, phase 1 study

    Pembrolizumab 400 mg every 6 weeks as first-line therapy for advanced melanoma (KEYNOTE-555): Results from cohort B of an open-label, phase 1 study by Graham Cohen, Bernardo Rapoport, Sze W. Chan, Paul Ruff, Ana Arance, Karmele Mujika Eizmendi, Baerin Houghton, Michael P. Brown, Robert M. Zielinski, Eva Muñoz Couselo, Megan Lyle, James R. Anderson, Lokesh Jain, Dinesh de Alwis, Mallika Lala, Omobolaji Akala, Elliot Chartash, Conrad Jacobs

    Published in PloS one
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancer

    Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancer by Grimison, Peter, Houghton, Baerin, Chatfield, Mark, Toner, Guy C., Davis, Ian D., Martin, Jarad, Hovey, Elizabeth, Stockler, Martin R.

    Published in BJU international
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Patterns of management and surveillance imaging amongst medical oncologists in A ustralia for stage I testicular cancer

    Patterns of management and surveillance imaging amongst medical oncologists in A ustralia for stage I testicular cancer by Grimison, Peter, Houghton, Baerin, Chatfield, Mark, Toner, Guy C., Davis, Ian D., Martin, Jarad, Hovey, Elizabeth, Stockler, Martin R.

    Published in BJU international
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  10. 10
    Intravesical chemotherapy plus bacille C almette‐ G uérin in non‐muscle invasive bladder cancer: a systematic review with meta‐analysis

    Intravesical chemotherapy plus bacille C almette‐ G uérin in non‐muscle invasive bladder cancer: a systematic review with meta‐analysis by Houghton, Baerin B., Chalasani, Venu, Hayne, Dickon, Grimison, Peter, Brown, Christopher S. B., Patel, Manish I., Davis, Ian D., Stockler, Martin R.

    Published in BJU international
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  11. 11
    Intravesical chemotherapy plus bacille Calmette-Guerin in non-muscle invasive bladder cancer: a systematic review with meta-analysis : Urological Oncology

    Intravesical chemotherapy plus bacille Calmette-Guerin in non-muscle invasive bladder cancer: a systematic review with meta-analysis : Urological Oncology by HOUGHTON, Baerin B, CHALASANI, Venu, HAYNE, Dickon, GRIMISON, Peter, BROWN, Christopher S. B, PATEL, Manish I, DAVIS, Ian D, STOCKLER, Martin R

    Published in BJU international
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: